Description
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
OncQuer TM Scout LB 56 Gene Test
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
TAT:
Specimen Type:
Genomics Single Test
Other Tests
-
260%
IGVH Somatic Hyper Mutation Assay
Colon and Lung Cancer marker
-
264%
OncQuer TM Germline Mutation Panel by NGS
Identification of gene mutations that increase risk of cancer or has therapeutic implications in an affected individual
OncQuer TM Germline Mutation Panel by NGS
Identification of gene mutations that increase risk of cancer or has therapeutic implications in an affected individual
-
264%
OncQuer TM Scout LB EGFR Sensitivity Test
Identification gene mutations leading to sensitivity to EGFR therapy
OncQuer TM Scout LB EGFR Sensitivity Test
Identification gene mutations leading to sensitivity to EGFR therapy
-
255%
GERMLINE BRCA 1 AND 2 – LAL PATH LAB
Panel of BRCA1&2 Genes
Reviews
There are no reviews yet.